Category Biology/Biotechnology

USC researchers have developed a groundbreaking ultrasound device that could reduce our reliance on addictive painkillers. A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no wires, and no opioids. Designed by USC and UCLA engineers, it reads brain signals, adapts on the fly, and bends naturally with your spine.

Chronic pain is a debilitating condition that severely impacts quality of life, often leading to reliance on opioid medications with their severe side effects and addiction risks. According to the U.S. Pain Foundation, 51.6 million Americans live with chronic pain. For over 17 million sufferers, their chronic pain is high-impact – frequently limiting their life or work activities.

Current implant...

A recent study has shed light on the brain structure differences associated with psychopathy—a condition known to be one of the strongest predictors of persistent violent behavior.

The findings are published in the journal European Archives of Psychiatry and Clinical Neuroscience.

Using advanced neuroimaging and the Julich-Brain Atlas, researchers from Forschungszentrum Jülich, RWTH Aachen University, Heinrich-Heine-University Düsseldorf, Georg August University, (Germany) and University of Pennsylvania (U.S.) have identified specific brain networks that appear to be structurally altered in individuals exhibiting psychopathic traits. The Atlas can be freely accessed via the EBRAINS Research Infrastructure.

The study examined structural MRI data from 39 adult male particip...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic migraines who took liraglutide, a GLP-1 receptor agonist, experienced over 50% fewer headache days and significantly improved daily functioning without meaningful weight loss. Researchers believe the drugs ability to lower brain fluid pressure is the key, potentially opening a completely new way to treat migraines. The effects were fast, sustained, and came with only mild side effects.

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at the European Academy of Neurology (EAN) Congress 2025.1

Researchers at the Headache Center of the University of Naples “Federico II” ...

People with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) have significant differences in their blood compared with healthy individuals, a new study reveals, suggesting a path toward more reliable diagnosis of the long-term debilitating illness. The paper is published in the journal EMBO Molecular Medicine.

The largest ever biological study of ME/CFS has identified consistent blood differences associated with chronic inflammation, insulin resistance, and liver disease.

Significantly, the results were mostly unaffected by patients’ activity levels, as low activity levels can sometimes hide the biological signs of illness, experts say.

The volume and cons...